World's Best Scientists 2026 revealed!
Olivier Chazouillères

Olivier Chazouillères

D-Index & Metrics

Medicine

D-Index
73
Citations
21939
World Ranking
19607
National Ranking
662

Olivier Chazouillères publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Olivier Chazouillères sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 298 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Olivier Chazouillères D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Olivier Chazouillères sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 73 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Olivier Chazouillères is affiliated with Université Paris Cité in France and primarily works within the field of Medicine, with a significant focus on Hepatology. Their research spans various aspects of liver diseases, encompassing diagnosis, treatment, immunity, and transplantation.

The scientist's work extensively covers the following main topics:

  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Hepatitis B Virus Studies

The subfields of study associated with their research include:

  • Hepatology
  • Epidemiology
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Oncology

Olivier Chazouillères has contributed to the academic literature with numerous papers, including several recent influential publications such as:

  • "EASL Clinical Practice Guidelines on sclerosing cholangitis," 2022, Journal of Hepatology
  • "Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis," 2021, The Lancet. Gastroenterology & Hepatology
  • "Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group," 2022, Journal of Hepatology
  • "Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta," 2020, Journal of Hepatology
  • "Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis," 2021, Journal of Hepatology

Their publication record shows frequent contributions to the following venues:

  • Journal of Hepatology
  • JHEP Reports
  • Alimentary Pharmacology & Therapeutics
  • Clinics and Research in Hepatology and Gastroenterology
  • Clinical Gastroenterology and Hepatology

Olivier Chazouillères has collaborated regularly with several coauthors, including:

  • Christophe Corpechot
  • Victor de Lédinghen
  • Georges-Philippe Pageaux
  • Fabrice Carrat
  • Nathalie Ganne-Carrié

Best Publications

  • EASL Clinical Practice Guidelines: management of cholestatic liver diseases

    Ulrich Beuers;Kirsten M. Boberg;Roger W. Chapman;Olivier Chazouillères

  • Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

    Henri Duboc;Sylvie Rajca;Sylvie Rajca;Dominique Rainteau;Dominique Rainteau;David Benarous

  • Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy

    Olivier Chazouillères;Dominique Wendum;Lawrence Serfaty;Sarah Montembault

  • Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria

    Christophe Duvoux;Françoise Roudot-Thoraval;Thomas Decaens;Fabienne Pessione

  • Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.

    Christophe Corpechot;Ludovico Abenavoli;Nabila Rabahi;Yves Chrétien

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

    Christophe Corpechot;Olivier Chazouillères;Alexandra Rousseau;Antonia Le Gruyer

  • Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

    Christophe Corpechot;Ahmed El Naggar;Armelle Poujol-Robert;Marianne Ziol

  • Determinants of outcome of compensated hepatitis C virus-related cirrhosis

    Lawrence Serfaty;Hugues Aumaître;Olivier Chazouillères;Anne-Marie Bonnand

  • Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.

    Christophe Corpechot;Olivier Chazouillères;Raoul Poupon

  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  • Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

    Edward K. Geissler;Andreas A. Schnitzbauer;Andreas A. Schnitzbauer;Carl Zülke;Philipp E. Lamby

  • Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

    Lawrence Serfaty;Tony Andreani;Phillipe Giral;Nicolas Carbonell

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis

    Christophe Corpechot;Fabrice Carrat;Armelle Poujol-Robert;Farid Gaouar

  • Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

    Michelle Rosenzwajg;Roberta Lorenzon;Patrice Cacoub;Hang Phuong Pham

  • Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.

    Christophe Corpechot;Farid Gaouar;Ahmed El Naggar;Astrid Kemgang

  • Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Sun Gou Ji;Brian D. Juran;Sören Mucha;Trine Folseraas

  • Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

    Christophe Hézode;Helene Fontaine;Celine Dorival;Fabien Zoulim

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Raoul Poupon
Raoul Poupon Sorbonne University
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Fabrice Carrat
Fabrice Carrat Sorbonne University
Albert Parés
Albert Parés University of Barcelona
François Durand
François Durand Université Paris Cité
Cyriel Y. Ponsioen
Cyriel Y. Ponsioen University of Amsterdam
Victor de Ledinghen
Victor de Ledinghen Grenoble Alpes University
Dominique Larrey
Dominique Larrey University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn't always mean following the traditional path to an MD. For those interested in starting their healthcare journey online, a variety of related degrees and programs offer practical alternatives. Many choose to start by enrolling in medical billing and coding schools with financial aid, gaining valuable administrative skills and a quick route to employment.

Another option is a practical nursing qualification, especially for those seeking accessible entry points. An lpn program without teas test can remove barriers to admission, allowing students to focus on core nursing skills sooner.

For those keen on the business side of healthcare, earning a degree from one of the best health administration degree programs online opens up leadership paths within hospitals and clinics.

Finally, working nurses who wish to advance their practice can explore rn to fnp bridge programs, providing a flexible route to becoming a family nurse practitioner.

Best Scientists Citing Olivier Chazouillères

Trending Scientists

Recently Published Articles